Nanalysis Scientific Corp. Announces Closing of Second Tranche to Fully Complete its $4,128,700 Offering

Nanalysis Scientific Corp. (" Nanalysis " or the " Company ", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce, further to its news releases dated April 21, 2023 April 26, 2023 and May 1, 2023 it has successfully closed the second and final tranche (the " Second Tranche ") of its $4,128,700 non-brokered private placement (the " Offering ").

Under the Second Tranche, the Company has issued a total of ‎3,142,500‎ units (" Units ") ‎at a price of $0.60 per Unit for gross proceeds of ‎$1,885,50‎0. Each Unit consists of one common share in the capital of the Company (a " Common Share ") and one Common Share purchase warrant (a " Warrant "). Each Warrant entitles the holder thereof to purchase one Common Share at a price of $0.80 per Common Share (the " Warrant Exercise Price ") at any time up to 4:00 p.m. ( Calgary time) on or before the date that is one year following the closing date of the Offering. The net proceeds of the Offering will be used by the Company for working capital purposes.

In connection with the Second Tranche, finders acting in connection with the Offering received fees in the aggregate amount of ‎‎$45,640.

Five directors participated in the placement for a total of ‎approximately ‎$209,400. A portion of the Offering constituted a related party ‎transaction within the ‎meaning of TSX Venture Exchange Policy 5.9 and Multilateral Instrument ‎‎61-101 (" MI 61-‎‎101 ") as certain insiders of the Company subscribed for an aggregate of 349,000 ‎Units pursuant ‎to the Second Tranche. The Company is relying on the exemptions from the ‎valuation and minority ‎shareholder approval requirements of MI 61-101 contained in sections ‎‎5.5(b) and 5.7(1)(a) of MI ‎‎61-101, as the fair market value of the participation in the Offering by insiders does not exceed ‎‎25% of the market capitalization of the Company, as ‎determined in accordance with MI 61-101. ‎The Company did not file a material change report ‎in respect of the related party transaction at ‎least 21 days before the closing of the Offering, which the Company deems reasonable in the ‎circumstances in order to complete ‎the Offering in an expeditious manner.‎

All securities issued in connection with the Offering will not be able to be traded in Canada , or ‎‎through the facilities of the TSX Venture Exchange, for a period of four months and one day ‎‎from the date of closing.‎ The Offering is subject to final TSX Venture Exchange acceptance.‎

About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1)

Nanalysis' business is what we term "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. In 2020 Nanalysis announced the launch of its100MHz device, the most powerful and most advanced compact NMR device ever brought to market.

Nanalysis' devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners.

In 2022 the Company acquired K'(Prime) Technologies Inc. (KPrime), a North American sales and service company of over 40 individuals who cover scientific instrumentation for pharma, food, chemical and oil & gas customers, as well as imaging systems for security applications.

Additionally in 2022, the Company acquired a 43% ownership in Quad Systems AG ("Quad Systems"), a Zurich-based Nuclear Magnetic Resonance (NMR) company focused on high-field NMR for pharmaceutical and other vertical markets.

Notice regarding Forward Looking Statements and Legal Disclaimer

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law relating to the use of net proceeds of the Offering, regulatory approval for the Offering and statements relating to the final TSX Venture Exchange approval and other matters ‎ancillary or incidental to the foregoing. ‎

All statements included herein, other than statements of historical fact, may be forward-looking information and such information involves various risks and uncertainties. Forward-looking information is often, but not always, identified by the use of words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia: https://www.prnewswire.com/news-releases/nanalysis-scientific-corp-announces-closing-of-second-tranche-to-fully-complete-its-4-128-700-offering-301815030.html

SOURCE Nanalysis Scientific Corp.

View original content to download multimedia: https://www.newswire.ca/en/releases/archive/May2023/03/c7068.html

News Provided by Canada Newswire via QuoteMedia

Nanalysis Scientific TSXV:NSCI Emerging Tech Investing

NSCI:CA

Nextech3D.ai Expands Offering to Ecommerce Imagery: Unveils Cutting-Edge 3D Model-AI Photo Rendering Services, Transforming 2D Photos into Dynamic Product Visuals

New ecommerce expansion with AI 3D-Photography Tools

Nextech3D.ai (OTCQX:NEXCF)(CSE:NTAR)(FSE:EP2), a patented 2D-3D Generative AI-Powered 3D model supplier (Patent #11,948,248) for Amazon, Miele, P&G, Kohls, Wesfarmers Group ``Bunnings" (Australia's largest listed company) and other major e-commerce retailers is adding Digital Photography and dynamic product visuals as part of its 3D model offerings. Now every 3D model that Nextech3D.ai creates will have stunning 2K, 4K, or even 8K photos to go with it for its ecommerce customers. This AI tool is expected to drive significant revenue for the company as each product listed for sale on an ecommerce platform requires a minimum of six 2D photos for listing, this offering allows the company to capitalize on this demand for 2D high res images while simultaneously increases the value of its 3D modeling business as it represents the all-in-one solutions for ecommerce sellers that sell on Amazon, Shopify and other platforms. The company has already signed up 10 existing customers for its digital photography offering representing over 6000+digital photos and will be offering it both as part of a 3D model bundle as well as a stand alone product offering for people that already have a 3D model opening up the ecommerce imagery market to the company. The company's analysis shows that creating and rendering 3D models is more cost-effective than traditional product photography, especially for products that are expensive to produce or difficult to photograph in real life. Once a 3D model is created, it can be easily manipulated and rendered from different angles without the need for physical prototypes or multiple photoshoots

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Aether Global Provides Update on Management Cease Trade Order

(TheNewswire)

Vancouver, B.C. TheNewswire - April 17, 2024 Aether Global Innovations Corp. (CSE:AETH) (OTC:AETHF) (Frankfurt:4XA) (WKN#A2N8RH), a leader in drone management and automation, is providing this update on the status of a management cease trade order (the "MCTO") granted on April 3, 2024 by the British Columbia Securities Commission under National Policy 12-203 - Management Cease Trade Order ("NP 12-203").

News Provided by TheNewsWire via QuoteMedia

Keep reading...Show less

NEO Battery Materials Appoints Renowned Battery Industry Pioneer Mr. Ricky Lee as Lead Managerial Advisor

T S X V : NBM ) ( OTC: NBMFF )

NEO Battery Materials Ltd. (" NEO " or the " C o mpan y "), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to appoint Mr. Ricky Lee, a renowned battery industry pioneer, as the Lead Managerial Advisor. Mr. Ricky Lee is a 35-year battery and energy industry executive with substantial experience with battery material and cell design, mass-production technology, and equipment & process development at globally distinguished companies.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

ARway.ai Signs Deal with George Mason University for Augmented Reality Campus Navigation and Experience

ARway.ai ("ARway" or the "Company") (CSE:ARWY)(OTCQB:ARWYF)(FSE:E65) is an AI powered Augmented Reality Experience platform with a disruptive no-code, no beacon spatial computing solution enabled by visual marker tracking with centimeter precision is pleased to announce that George Mason University is signed up for the ARway platform and will be deploying ten spatial maps across the university campus. The rollout is part of a 2024 project aimed at enhancing the campus navigation and campus experience for students. GMU has an undergraduate enrollment of approximately 27,014 and the campus size is 817 acres. ARway.ai is seeing demand from across the globe for University Campus deployments, and is currently deployed in the Middle East at the Suleyman Demirel University in Turkey, In the EU at the Institut für Innovations- und Informationsmanagement (iFii), University of Applied Sciences Brandenburg. ARway has also signed multiple new subscriptions with prestigious universities around the globe including Bicol University in Indonesia, DHA Suffa University in Pakistan, University of Alberta in Canada, University College Cork in the UK and German University of Technology in Oman

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Cypher Metaverse Inc. Announces Debt Settlements

Cypher Metaverse Inc. (CSE:CODE) ("CODE" or the "Company") announces today that it has entered into settlement agreements that will see $149,215 of debt settled by the issuance of 1,755,470 shares at a deemed price of $0.085, and the Company's balance sheet much improved

No finders fees will be paid. The securities issued will be subject to a four-month and one-day hold period from closing.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce further positive interim results from its study with The Giacomantonio Immuno-Oncology Research Group at Dalhousie University (the "Study"). The Company was provided with data from the Study that indicates the response in a pre-clinical triple negative breast cancer model treated with the combination of Sona's targeted hyperthermia therapy ("THT") and interleukin-2 ("IL-2"), a standard immunotherapy, is statistically significantly superior to results observed from treatment with either agent individually or the control group. This second phase of the Study has documented that, in a cohort of six animals, 66 of treated triple negative breast cancer, the most aggressive and therapy resistant form, mouse tumors bearing gold nanorods and IL-2 responded to the combination therapy, resulting in a flattening of the tumor growth curves, as shown in the below graph. The generation of hyperthermia involved exposing tumors previously injected intratumorally with Sona's gold nanorods and IL-2 to a single dose of near infrared light.